Ronald Blue Trust Inc. Buys 3,125 Shares of Abbott Laboratories (NYSE:ABT)

Ronald Blue Trust Inc. boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 16.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,805 shares of the healthcare product maker’s stock after purchasing an additional 3,125 […]

Related Keywords

Danielj Starks ,Andreaf Wainer , ,Ronald Blue Trust Inc ,Securities Exchange Commission ,Wells Fargo Company ,Capstone Triton Financial Group ,Citigroup ,Mount Yale Investment Advisors ,Sageworth Trust Co ,Family Wealth Advisors ,Abbott Laboratories ,Morgan Stanley ,Schaper Benz Wise Investment Counsel Inc ,Ronald Blue Trust ,Free Report ,Blue Trust ,Wise Investment Counsel ,Yale Investment Advisors ,Wealth Advisors ,Triton Financial Group ,Exchange Commission ,Director Daniel ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,Nyse Abt ,Abt ,Medical ,00282410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,